ABSTRACT
Introduction
Kidney ischemia-reperfusion (I/R) injury is a common clinical, pathological process. Acute renal failure is a clinical disease, which occurs in 5% of the total incidences of hospitalized patients and reaches 25% in severe illness 1 . Ischemia is the main cause of acute renal failure, and it causes injury to the kidney.
Although the recovery of blood flow is essential for the survival of ischemic kidney tissue, this may paradoxically cause additional damage to the kidney. Renal tubular epithelial cell apoptosis is the main pathophysiological change that occurs in I/R, and it determines the extent of damage to the kidney function. is associated with aggravation of inflammatory responses in numerous diseases 8, 9 including kidney I/R injury 10 . Moreover, it has been verified that the expression level of COX2 increased after I/R in the kidney of rats 11 while inhibition of COX2 was beneficial and improved renal function 10 .
Metformin may aggravate renal insufficiency, which in its severe form is a contraindication for the administration of metformin. However, we hypothesized that low doses of metformin may attenuate renal I/R injury by increasing the energy supply to the ischemic tissue and reducing the expression of inflammatory cytokines. Furthermore, the simultaneous occurrence of these metformin-induced actions may be beneficial and further protect the renal function.
Methods
The experimental animal protocol used in our study was approved by the Animal Ethics Review Committee of the Wuhan University, and the procedures were carried out accordance with the recommendations in the Guide for the Care and Use of Laboratory The rats were anesthetized by intraperitoneal (ip) injection of pentobarbital (50 mg/kg), administered 500 U of heparin ip, and then placed on an electric heating pad to maintain their body temperature at 37°C. The rats were divided into three groups using a random number table (n = 6). The groups included the sham operated (S), I/R, and metformin (E) groups.
All the groups underwent a right nephrectomy while the I/R group alone was further subjected to 45 min of renal ischemia of left the kidney after which the renal arteriovenous perfusion was restored. For 3 days prior to establishing the I/R model, group E was administered metformin (0.125 mg·kg -1 ·d -1 , ip)
while the S and I/R groups were administered the same volume of normal saline.
Reagents and drugs
The cell apoptosis detection kit was purchased from 
Detection of blood urea nitrogen (BUN) and creatinine (Cr)
After a 24-h reperfusion, all the rats were euthanized and 5-mL blood samples were collected from the inferior vena cava, and centrifuged for the determination of concentration of blood urea nitrogen (BUN) and creatinine (Cr). These parameters were measured in the blood using standard techniques with an Olympus AU 2700 Analyzer (Olympus Optical Co., Ltd., Tokyo, Japan).
Hematoxylin and eosin (H&E) staining and immunohistochemical analysis
After the blood samples had been collected, the left kidneys of all rats were harvested, and tissue samples were fixed with 4% paraformaldehyde, embedded in paraffin according to standard procedures. Then the tissue was sectioned onto slides, gradually deparaffinized, rehydrated, and subsequently observed using hematoxylin and eosin (H&E) staining. The morphological assessment was performed by an experienced renal pathologist who was blinded to the experimental grouping, using standard methodology. The histological grading standard used was the Jablonski grade 
Determination of cell apoptosis
To observe cell apoptosis induced by ischemia, an in-situ apoptosis detection kit (Promega, USA) was used and a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed following the manufacturer's instructions.
The normal and apoptotic cell nuclei were blue-green and different shades of brown, respectively. 
Western blot analysis
The kidney tissue protein samples were extracted and quantitated using the bicinchoninic acid (BCA) assay, and stored at -70°C until analyzed. Briefly, protein samples were prepared and separated (50 μg/lane) using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a nitrocellulose membrane (Bio-Rad). The membrane was blocked with 5% nonfat dry milk in Tris-buffered saline plus Tween (TBST) buffer and then incubated with polyclonal primary antibodies against caspase-3, COX-2, AMPK, and pAMPK (1:100 each) and monoclonal rabbit anti-rat β-actin (1:2000) overnight at 4°C.
After extensively washing the membranes with TBST buffer, they were incubated with their respective secondary antibodies for 1 h. The proteins were detected using an ECL system kit (Pierce Biotechnology, Beijing, China) and captured on lightsensitive X-ray film (Kodak, Shanghai, China). The optical densities were analyzed using the ImageJ software (NIH, Bethesda, MD, USA).
Statistical analysis
All data was statistically analyzed using the statistical package for the social sciences (SPSS) version 18.0 (SPSS Inc., Chicago, IL, USA). The means of the different groups were compared using the Student's t-test and differences were considered statistically significant p<0.05.
Results

Effect of metformin on renal function
Rats in the I/R and E groups showed significant increases in serum BUN and Cr levels compared with the S group rats (p<0.05). Furthermore, the I/R-induced increase improved following treatment with metformin; however, there was no significant difference between the I/R and E groups ( 
Effect of metformin on renal histopathological changes
The H&E stained kidney tissue sections showed that there were no obvious glomerular and renal tubular necrotizing pathological changes in the S group. However, kidney I/R resulted in significant renal injury, as evidenced by acute tubular necrosis, renal tubular expansion, renal tubular epithelial cell exfoliation, and development of proteinaceous casts. There were less renal tubular necrotizing changes in the group E than there were in the I/R group. The Jablonski grade analysis of severe acute tubular necrosis results revealed significantly lower scores for the E group than for the I/R group. Metformin preconditioning significantly reduced the Jablonski grade and AI in group E compared with that of the I/R group (p<0.05). Compared to I/R group, Metformin preconditioning improved the renal dysfunction induced by I/R injury, although there were no significant differences between groups E and I/R (p>0.05). Compared with group S, the I/R and E groups exhibited higher serum Cr and BUN levels as well as Jablonski grade and AI indices (p<0.05, Table 1 and Figure 1 ).
Furthermore, compared to the S group, the results of the TUNEL staining also revealed a significant increase in the AI of the E and I/R groups (p<0.05), although that of group E was lower than that of the I/R group was (p<0.05, Table 1 , Figure 2 ). FIGURE 1 -Metformin preconditioning improved morphological feature after renal ischemia/reperfusion (IR) injury. Compared to group S, I/R and E groups exhibited more tubular necrosis, renal tubular expansion, renal tubular epithelial cellular exfoliation, and development of proteinaceous casts. Renal tubular necrotizing pathological changes in group E were fewer than in I/R group. Jablonski grade of severe acute tubular necrosis was significantly lower in group E than in I/R group (p<0.05, magnification ×200). S, sham operated; E, metformin.
FIGURE 2 -Metformin preconditioning attenuated apoptosis of tubular epithelial cells. TUNEL staining shows apoptosis index increased significantly in groups E and I/R compared with group S (p<0.05). Apoptosis index of group E was lower than that of I/R group (p<0.05, magnification ×200). TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; S, sham operated; I/R, ischemia reperfusion; E, metformin.
Effect of metformin on expression of pAMPK, COX-2, and Caspase-3
The results of the immunohistochemistry analysis showed that the expression levels of COX-2 and Caspase-3 in the E and I/R groups were significantly higher than those in the S group were. However, the E group levels were much lower than those of the I/R group were (Figure 3) . Furthermore, the western blot analysis revealed that the expressions of COX-2, Caspase-3, and pAMPK in groups E and I/R were significantly higher than those in the S group were (p<0.05), while the expression of pAMPK was much more in group E than it was in the I/R group (p<0.05). In addition, the expression levels of COX-2 and Caspase 3 were lower in group E than they were in the I/R group (p<0.05),
However, there was no significant difference in the expression of AMPK between groups E and I/R (p>0.05, Figure 4) .
FIGURE 3 -Effect of metformin preconditioning on cyclooxygenase (COX)-2 and Caspase 3 expressions after renal ischemia-reperfusion (I/R).
Immunohistochemistry shows expression levels of COX2 and Caspase3 in groups R and I/R were obviously higher than they were in group S. However, expression levels of COX2 and Caspase 3 in group E were much lower than they were in I/R group (magnification ×200). S, sham operated; I/R, ischemia reperfusion; E, metformin. Expressions of COX-2, Caspase 3, and pAMPK in groups E and I/R were significantly higher than they were in group S (p<0.05). Expression of pAMPK was significantly higher in group E than it was in I/R group (p<0.05), while levels of COX-2 and Caspase 3 were lower in group E than they were in I/R group (p<0.05). However, no significant differences were found in expression of AMPK between groups E and I/R (p>0.05). Bars represent means ± S.E.M. (n = 6), * p< 0.05 vs S group, # p< 0.05 vs I/R group. S, sham operated; I/R, ischemia reperfusion; E, metformin.
A B D E C Discussion
I/R injury is known to be induced by the ischemia that occurs after blood flow recovery and restoration to tissues and organs, which further aggravates the injury. It is generally accepted that I/R injury is associated with a series of inflammatory reaction processes, which include endothelial cell activation, expression of adhesion molecules, adhesion, aggregation and activation of leukocytes and platelets, release of oxygen free radicals, and cellular calcium overload as well as apoptosis that is mediated by these processes. Acute kidney injury caused by I/R is a clinical syndrome the leads to rapid kidney dysfunction and high mortality rates 13, 14 . However, the mechanisms underlying the development I/R injury have not been fully elucidated.
The main characteristics of ischemic diseases include inflammatory responses, metabolic disorders, and cell necrosis 15, 16 .
AMPK is an evolutionarily conserved serine/threonine kinase and one of the key energy regulatory factors, which could inhibit constructive metabolism and promote the oxidation of fatty acid, glucose uptake, and glycolysis following its activation 17 . All these processes facilitate the increase in energy supply to the ischemic tissue.
There are several known physiological, pharmacological, and natural activators of AMPK, and a few of these are currently used clinically 18, 19 such as metformin. Accumulating evidence has shown that metformin inhibits the proliferation of prostate, ovarian, colon, and pancreatic cancer cells [20] [21] [22] . Furthermore, studies with metformin have shown that inflammatory mediators such as TNF-α, IL-6, interferon (INF)-γ, and nuclear factor kappalight-chain-enhancer of activated B cells (NF-κB) were decreased following supplementation with metformin [23] [24] [25] . Nevertheless, the effect of metformin on the kidney ischemia/reperfusion has not been studied yet. Therefore, in the present study, we investigated the effects of metformin on renal tubular epithelial cell apoptosis and inflammation in a rat model of kidney I/R injury.
Metformin is an oral hypoglycemic agent that is commonly used in the treatment of type 2 diabetes mellitus. 
